This article on the International Business Times site appeared in August but I believe MultiCell Technologies is a good long-term stock to consider. Take a look, MCET is still pretty cheap at 0.02 :
MultiCell Technologies, Inc. (MCET.OB) is 'One to Watch'
Headquartered in Woonsocket, Rhode Island, MultiCell Technologies, Inc. is an integrated biopharmaceutical company. Trading on the OTCBB, their commitment is to the development of breakthrough therapeutics based on a portfolio of therapeutic candidates and patented drug development technologies. The company plans to pursue strategic alliances to better penetrate the various markets for their therapeutics.
The company’s drug development program focuses on the modulation of the immune system. Their lead drug candidates include drugs to treat multiple sclerosis (MS)-related chronic fatigue, relapsing-remitting MS, type-1 diabetes, and infectious disease. MultiCell Technologies, Inc.’s therapeutic pipeline includes MCT-125, which is directed at treating chronic fatigue in MS patients. MCT-125 completed a 138 patient Phase II clinical trial and demonstrated strong efficacy in reducing fatigue in MS patients....Click here to read the rest.
Subscribe to:
Post Comments (Atom)
My man what is your openion on ZVTK and DLAD.
ReplyDeleteI think ZVTK is worth dumping some money into. It's a real company and with a real product and it's still a sub-penny stock that's moving up today. Got for it. I don't know about DLAD, I'll check it out.
ReplyDelete